BTIG Raises GE HealthCare (GEHC) PT to $89 on Optimism for Q3 MedTech Results

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks to buy right now. On October 13, BTIG analyst Ryan Zimmerman raised the firm’s price target on GE HealthCare to $89 from $87 and kept a Buy rating on the shares, which came as part of BTIG’s broader research note previewing Q3 2025 results for the MedTech industry. Sentiment in the MedTech sector is currently weighed down, but Zimmerman believes that the near-term quarterly results may be better than feared because most of these headline risks are not expected to take effect until later.

Additionally, on October 20, GE HealthCare announced a collaboration with two prominent US health systems: The Queen’s Health Systems in Honolulu, HI, and Duke Health in Durham, NC, to accelerate the development of its new AI-driven hospital operations software. The solution is a cloud-first SaaS offering that will join GE HealthCare’s CareIntellect family of applications. Both health systems will contribute their frontline clinical and operational expertise to inform the software’s development.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) develops, manufactures, and markets products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the US, Canada, and internationally.

While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.